Dr. Burton A. Liebross, MD

Dr. Liebross practices at Cedars-Sinai Medical Center in Los Angeles, California, part of Cedars-Sinai Health System.

Dr. Liebross' NPI, 1659350718, was assigned on January 16, 2006. Dr. Liebross graduated from Chicago Medical School at Rosalind Franklin University of Medicine and Science in 1975. Dr. Liebross holds California license G32169.

Dr. Liebross' primary practice is Cedars-Sinai Medical Center, at 8700 Beverly Blvd, Los Angeles, CA 90048 in Los Angeles County. The practice phone is (310) 423-5000.

Dr. Liebross' primary practice is Cedars-Sinai Medical Center in Los Angeles, California, part of Cedars-Sinai Health System. Dr. Liebross is also affiliated with Providence Cedars-Sinai Tarzana Medical Center. The medical group on file is Cedars-Sinai Medical Group. Dmand AI also links Dr. Liebross to 4 more home health agencies and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Liebross practices, 7 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Liebross' primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Liebross is board certified in internal medicine by the American Board of Internal Medicine. Dr. Liebross is licensed in California.

Dmand AI lists acute kidney failure, chronic anemia, chronic kidney disease, fluid and electrolyte imbalances, hypercalcemia, kidney cysts and parathyroid gland disorder among the conditions Dr. Liebross treats.

CMS data shows 7,034 Medicare services from Dr. Liebross across 44 procedure codes in 2024, for 795 Medicare patients. Medicare paid $264,826 for them. Every service was in an office.

CMS counts 795 Medicare patients who saw Dr. Liebross in 2024. The largest group is 75 to 84, with 352 patients. 75% of them have high cholesterol, and 69% have high blood pressure. 5% are also on Medicaid. Their average risk score is 1.10, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Liebross' median patient age at 75, with 51% women.

In 2024, Dr. Liebross wrote 9,063 Medicare Part D claims for 683 patients. 86% of them were for generic drugs. CMS names the drug for 8,272 of them, across 140 drugs with 11 or more claims each, at $1,041,782 in total drug cost. In 2023, CMS named 7,549 claims across 129 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Liebross for performance year 2024, reported as part of a group. Dr. Liebross accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Liebross as offering telehealth.

CMS Open Payments shows 446 general payments to Dr. Liebross from 58 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 87% of the total. Amgen Inc. paid the most, $1,958.

Dmand AI lists 5 awards for Dr. Liebross, most recently CMS Stage 1 EHR in 2013. Dr. Liebross serves on PAIC.

Dr. Liebross graduated from Chicago Medical School at Rosalind Franklin University of Medicine and Science in 1975. Dr. Liebross is a member of ACP.

Dr. Liebross is in network with 15 carriers, including Blue Cross Blue Shield of Michigan, United Healthcare and Elevance. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.